Akebia Therapeutics | AKBA - Lucro Operacional





Lucro Operacional Alterar Data
Acadia Pharmaceuticals USD 71.72M 33.88M 2026-09
Agios Pharmaceuticals USD -110.55M 527K 2026-06
Akebia Therapeutics USD -5.45M 9.4M 2025-12
Alnylam Pharmaceuticals USD 179.66M 67.06M 2026-09
Amgen USD 4.68B 65M 2026-09
Ardelyx USD -12.42M 20.37M 2026-06
Astellas Pharma JPY 132.59B 52.76B 2026-09
AstraZeneca USD 4.66B 1.5B 2026-09
Bayer EUR 129M 698M 2026-09
BioMarin Pharmaceutical USD 205.6M 100M 2026-09
Celltrion KRW 19.31B 6.4B 2026-06
Cspc Pharmaceutical CNY 206.26M 1.02B 2025-12
Deva Holding AS TRY 964.87M 240.32M 2023-09
Dianthus Therapeutics USD -61.48M 14.95M 2026-06
Exelixis USD 268.42M 20.01M 2026-09
Fresenius Medical Care EUR 384M 153.27M 2026-09
GlaxoSmithKline GBP 2.86B 251M 2026-09
Ionis Pharmaceuticals USD -130M 27.71M 2026-09
Ironwood Pharmaceuticals USD 33.22M 7.58M 2024-12
J&J USD 6.47B 1B 2026-09
Kangmei Pharma CNY -35.26M 24.32M 2026-06
Karyopharm Therapeutics USD -26.76M 8.92M 2026-03
Knight Therapeutics CAD 6.21M 3.27M 2025-12
Laboratorios Farma EUR 135.05M 49.84M 2023-12
Lexicon Pharmaceuticals USD -14.78M 2.59M 2025-12
Malin Corporation EUR -1.1M 400K 2024-12
Medical Developments International AUD -36K 444K 2025-12
Moderna USD 130M 945M 2026-09
Nektar Therapeutics USD -38.26M 19.17M 2026-03
Neuren Pharmaceuticals AUD 17.01M 11.56M 2025-12
Organigram Holdings CAD 5.33M 15.12M 2026-06
Ovoca Bio EUR -173K 990K 2025-12
Pharma Mar EUR 7.65M 9.06M 2026-09
Prothena USD -18.69M 44.48M 2026-06
PTC Therapeutics USD 148.98M 103.09M 2026-06
Qiagen NV USD 141.4M 24.77M 2026-06
Regeneron Pharmaceuticals USD 1.42B 675.7M 2026-06
Roche Holding CHF 11.46B 1.91B 2026-06
Sanofi EUR 4.72B 2.34B 2026-09
Sarepta Therapeutics USD -9.04M 22.33M 2026-09
Sartorius EUR 179.8M 15.8M 2026-09
Sino Biopharmaceutical CNY 5.18B 3.32B 2025-06
Tectonic Therapeutic USD -24.22M 3.08M 2026-06
Tilray USD -20.01M 9.34M 2025-09
Vanda Pharmaceuticals USD -40.66M 29.66M 2024-12
Zealand Pharma A/S -539M 168.05M 2026-03
Zz Pientze Pharmaceu CNY 222.81M 140.02M 2026-09